These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 37158958
1. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer. Ren L, Yang X, Liu J, Wang W, Liu Z, Lin Q, Huang B, Pan J, Mao X. Cancer Cell Int; 2023 May 08; 23(1):85. PubMed ID: 37158958 [Abstract] [Full Text] [Related]
2. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J, Liang Y, Gu JJ, Huang Y, Wang B. Front Genet; 2022 May 08; 13():991162. PubMed ID: 36353118 [Abstract] [Full Text] [Related]
3. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S. Front Genet; 2022 May 08; 13():906496. PubMed ID: 35938009 [Abstract] [Full Text] [Related]
4. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation. Wang T, Zhou Z, Wang X, You L, Li W, Zheng C, Zhang J, Wang L, Kong X, Gao Y, Sun X. Front Genet; 2022 May 08; 13():929035. PubMed ID: 36081998 [Abstract] [Full Text] [Related]
5. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs. Gao Y, Ren J, Chen K, Guan G. J Gastrointest Oncol; 2024 Feb 29; 15(1):203-219. PubMed ID: 38482248 [Abstract] [Full Text] [Related]
6. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. Dai YY, Gao YP, Chen LX, Liu JS, Zeng C, Zhou JD, Wu HL. Front Genet; 2022 Feb 29; 13():930446. PubMed ID: 36110218 [Abstract] [Full Text] [Related]
7. N7-methylguanosine-related lncRNAs: Distinction between hot and cold tumors and construction of predictive models in colon adenocarcinoma. Cheng Z, Wang J, Xu Y, Jiang T, Xue Z, Li S, Zhao Y, Song H, Song J. Front Oncol; 2022 Feb 29; 12():951452. PubMed ID: 36185235 [Abstract] [Full Text] [Related]
8. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J, Huang Z, Lin H, Cheng W, Lai J, Li J. BMC Cancer; 2022 Nov 04; 22(1):1132. PubMed ID: 36333719 [Abstract] [Full Text] [Related]
9. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. Zhao B, Fang F, Liao Y, Chen Y, Wang F, Ma Y, Wei C, Zhao J, Ji H, Wang D, Tang D. BMC Bioinformatics; 2023 Mar 19; 24(1):100. PubMed ID: 36935487 [Abstract] [Full Text] [Related]
10. A potential biological signature of 7-methylguanosine-related lncRNA to predict the immunotherapy effects in bladder cancer. Xie S, He J, Feng B, Rao D, Wang S, He Y. Heliyon; 2023 May 19; 9(5):e15897. PubMed ID: 37215925 [Abstract] [Full Text] [Related]
11. Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma. Zhang C, Zhou D, Wang Z, Ju Z, He J, Zhao G, Wang R. Front Genet; 2022 May 19; 13():907754. PubMed ID: 35754819 [Abstract] [Full Text] [Related]
12. Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. Li Y, Zhao K, Wu R, Wang J, Wang Q, Xiong Q, Xie F, Lei H, Feng P. J Gastrointest Oncol; 2023 Jun 30; 14(3):1392-1411. PubMed ID: 37435203 [Abstract] [Full Text] [Related]
13. N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma. Ming J, Wang C. Front Genet; 2022 Jun 30; 13():871899. PubMed ID: 35495133 [Abstract] [Full Text] [Related]
14. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Yang C, Zhang L, Hao X, Tang M, Zhou B, Hou J. Curr Oncol; 2022 Dec 28; 30(1):430-448. PubMed ID: 36661684 [Abstract] [Full Text] [Related]
15. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer. Dai D, Zhuang H, Shu M, Chen L, Long C, Wu H, Chen B. Heliyon; 2024 Apr 30; 10(8):e29326. PubMed ID: 38628712 [Abstract] [Full Text] [Related]
16. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer. Li Z, Zhao J, Huang X, Wang J. Sci Rep; 2023 Mar 15; 13(1):4302. PubMed ID: 36922569 [Abstract] [Full Text] [Related]
17. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. Zhong S, Chen S, Lin H, Luo Y, He J. BMC Urol; 2023 Nov 15; 23(1):186. PubMed ID: 37968670 [Abstract] [Full Text] [Related]
18. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma. Yang S, Zhou J, Chen Z, Sun Q, Zhang D, Feng Y, Wang X, Sun Y. Front Oncol; 2022 Nov 15; 12():934928. PubMed ID: 35992788 [Abstract] [Full Text] [Related]
19. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers. He CM, Zhang XD, Zhu SX, Zheng JJ, Wang YM, Wang Q, Yin H, Fu YJ, Xue S, Tang J, Zhao XJ. Front Genet; 2022 Nov 15; 13():998147. PubMed ID: 36226166 [Abstract] [Full Text] [Related]
20. The Risk Correlation between N7-Methylguanosine Modification-Related lncRNAs and Survival Prognosis of Oral Squamous Cell Carcinoma Based on Comprehensive Bioinformatics Analysis. Xu Y, Zou X, Mei J. Appl Bionics Biomech; 2022 Nov 15; 2022():1666792. PubMed ID: 36060561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]